Sponsored Applicants Clause Samples

The 'Sponsored Applicants' clause defines the terms and conditions under which an organization or individual may sponsor another party's application, typically for employment, immigration, or program participation. This clause outlines the responsibilities of the sponsor, such as providing necessary documentation, financial support, or compliance with relevant laws and regulations. Its core practical function is to clarify the obligations and expectations of both the sponsor and the applicant, thereby reducing misunderstandings and ensuring that all parties are aware of their roles in the sponsorship process.
Sponsored Applicants. The term "
View SourceView Similar (7)
Sponsored Applicants. ‌ 1. The Canadian Resident Matching Service (“CaRMS”); 2. The U.S. military service; or
View SourceView Similar (4)
Sponsored Applicants. A sponsored applicant may only be withdrawn from the Match by the applicant’s medical school official or administrator.
View SourceView Similar (3)
Sponsored Applicants. The term "sponsored applicant" refers to an applicant who is a student enrolled in a medical school accredited by the Liaison Committee on Medical Education ("LCME"). Sponsored applicants’ eligibility to participate in the Main Residency Match and to enter graduate medical education training on July 1 in the year of the Match shall be verified by their medical schools by the Rank Order List Certification Deadline. A senior student who was withdrawn from the Match may accept a position outside the Match no earlier than 12:00 p.m. eastern time on Wednesday of Match Week and only if training will begin on or after July 1 and before February 1 in the year immediately following the Match; however, if the student elects to participate in the Match the following year, the student will be sponsored.
View SourceView Similar (2)
Sponsored Applicants. The term "sponsored applicant" refers to a student enrolled in a medical school accredited by the Liaison Committee on Medical Education (LCME) or a student enrolled in a school accredited by the American Osteopathic Association (AOA) Commission on Osteopathic College Accreditation (COCA) at the time of registration for the Match. A sponsored applicant’s eligibility to participate in the Main Residency Match and to enter graduate medical education on July 1 in the year of the Match shall be based on the graduation requirements of the applicant’s medical school and shall be verified by the applicant’s medical school no later than the Rank Order List Certification Deadline. A sponsored applicant may withdraw from the Main Residency Match only through the applicant’s medical school official. Medical school officials shall determine the eligibility of their sponsored applicants to enter graduate medical education prior to the Rank Order List Certification Deadline. If the medical school official determines that a sponsored applicant is ineligible to enter graduate medical education on July 1 in the year of the Match, the medical school shall withdraw the applicant from the Match and notify the NRMP prior to the Rank Order List Certification Deadline. If the medical school official determines after the Rank Order List Certification Deadline or after the Match results have been released that a sponsored applicant is ineligible to enter graduate medical education by July 1 in the year of the Match, the school shall immediately notify the NRMP in writing. A sponsored applicant who is withdrawn from the Main Residency Match by the medical school official as a result of ineligibility may accept a position outside the Match no earlier than 12:00 p.m. eastern time on Wednesday of Match Week as long as training will begin on or after July 1, 2020 and before February 1, 2021. Students who are withdrawn due to ineligibility and who elect to participate in the Match the following year will be sponsored applicants. Sponsored applicants who are withdrawn from the Main Residency Match for reasons other than ineligibility may accept a position outside the Match provided training begins before February 1, 2021.
View Source
Sponsored Applicants. The term "sponsored applicant" refers to an applicant who is a student enrolled in a medical school accredited by the Liaison Committee on Medical Education ("LCME") whose ▇▇▇▇ has determined that the applicant is eligible to participate in the Main Residency Match.
View Source
Sponsored Applicants 
View SourceView Similar (5)

Related to Sponsored Applicants

  • Eligible Applicants The rules of eligibility of project promoters and project partners are set in Article 7.2 of the Regulation.

  • Applicants If the NRMP's investigation of an alleged Match violation by an applicant results in a finding that an applicant has committed a violation of this Agreement, the processing of the applicant's rank order list may be interrupted. The NRMP at its discretion may withdraw the applicant from the SMS Match. If a matched applicant is the subject of a violation investigation, the program to which the applicant matched may not fill the position with another applicant until the NRMP has issued the Final Report or granted a waiver, whichever is earlier. If the violation investigation has not concluded by the start date of training, the program shall begin training the matched applicant unless NRMP has granted a waiver or issued a deferral. The NRMP’s Final Report on the confirmed violation will be delivered to the applicant with copies to: (1) the applicant's medical school official, with a request that the Final Report be placed in the applicant’s permanent file (2) the Educational Commission for Foreign Medical Graduates if the applicant is a graduate of an international medical school (3) the NRMP institutional official and the director of the program to which the applicant matched (4) the NRMP institutional official and the director of the program to which the applicant has applied or switched (if known) (5) the party who originally reported the violation (6) the NRMP Executive Committee (7) the American Board of Medical Specialties (8) the American Osteopathic Association (9) the applicant's residency program director (10) the Federation of State Medical Boards if the applicant is to be permanently identified as a Match violator or permanently barred from future NRMP Matches (11) any parties whom the NRMP has determined are relevant to its investigation (12) state medical licensure boards, if requested by the applicant In addition, the applicant may be barred from subsequent NRMP Matches and/or identified as a Match violator to participating programs for one to three years or permanently, as determined by the NRMP. The applicant also may be barred for one year from accepting an offer of a position or a new training year, regardless of the start date, in any program sponsored by a Match-participating institution, and/or starting a position or a new training year in any program sponsored by a Match-participating institution if training would commence within one year from the date of issuance of the Final Report. Further, any applicant who has been denied a waiver of a binding commitment and who does not accept the matched position may be barred for one year from accepting an offer of a position or a new training year, regardless of the start date, in any program sponsored by a Match- participating institution and/or from starting a position or a new training year in any program sponsored by a Match- participating institution if training would commence within one year from the date of the NRMP's decision on the waiver. The decision conveyed in the Final Report will be displayed in the R3 system Applicant Match History for one to three years or permanently, as determined by the NRMP. Term limits of any sanction(s) imposed for the violation will be included to identify the length of time the action is in effect. The NRMP has sole discretion to determine which of the sanctions described above shall be applied in the event an applicant violates this Agreement. Failure to comply with sanctions levied as a result of a confirmed violation that is final may result in a new investigation and additional sanctions.

  • REFERRED CLIENT From time to time, ▇▇▇▇.▇▇▇ will refer potential clients to the real estate agents affiliated with the Recipient Broker identified above. (“Recipient Agent”) Each potential client that is presented with the Recipient Broker/Recipient Agent’s contact information by ▇▇▇▇.▇▇▇ shall be deemed a “Referred Client” as of the date ▇▇▇▇.▇▇▇ identifies such client to Recipient Broker and/or Recipient Agent. ▇▇▇▇.▇▇▇ will identify a Referred Client to Recipient Broker and/or Recipient Agent by either (i) sending an email and/or text message to Recipient Broker and/or Recipient Agent that includes the Referred Client’s contact information (ii) sending Recipient Broker and/or Recipient Agent a monthly report and agent portal that includes all Referred Clients who received Recipient Broker/Agent’s contact information through the ▇▇▇▇.▇▇▇ platform. Each monthly report will detail the Client Name, Address, and Date and Time the Recipient Broker/Agent’s information was provided to the Referred Client.

  • Orally Administered Anticancer Medication In accordance with RIGL § 27-20-67, prescription drug coverage for orally administered anticancer medications is provided at a level no less favorable than coverage for intravenously administered or injected cancer medications covered under your medical benefit.

  • PRODUCTS MANUFACTURED IN PUBLIC INSTITUTIONS Bids offering Products that are manufactured or produced in public institutions will be rejected.